Global Major Histocompatibility Complex (MHC) Tetramer Market Growth (Status and Outlook) 2025-2031

March 2025 | 91 pages | ID: GED62A29729FEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to this study, the global Major Histocompatibility Complex (MHC) Tetramer market size will reach US$ 20.6 million by 2031.

An MHC tetramer is a laboratory tool used to study antigen-specific T cells. It consists of four major histocompatibility complex (MHC) molecules bound to a specific peptide and labeled with a fluorescent tag. These tetramers can bind to T cell receptors (TCRs) on the surface of T cells that recognize the specific peptide-MHC complex. By using flow cytometry, researchers can identify and quantify antigen-specific T cells, making MHC tetramers a valuable tool for immunological studies, including vaccine development, cancer immunotherapy, and infectious disease research.

In 2023, North America accounted for the largest sales share of the MHC tetramer market. The region is characterized by a large number of pharmaceutical R&D service providers. Meanwhile, Asia Pacific is expected to witness the highest CAGR during the forecast period.

The major global companies of Major Histocompatibility Complex (MHC) Tetramer include MBL Life Science, ProImmune, BioLegend, KACTUS, Creative Biolabs, immunAware, HELIXGEN, ACROBiosystems and etc. In 2023, the world's top three vendors accounted for approximately 56.50% of the revenue.

In terms of application, the continued research demand for cancer immunotherapy and adoptive T cell therapy and immune responses to emerging and re-emerging viral infectious diseases such as COVID-19, HIV and influenza is the main reason driving the MHC tetramer market. In 2023, MHC tetramers for cancer research accounted for approximately 48.00% of the market.

Currently, the MHC tetramer market mainly consists of two types: MHC-I and MHC-II. MHC-I is mainly used for research on cancer, viruses, bacteria, etc., and MHC-II is mainly used for research on viruses, bacteria, allergens, etc. In 2023, the sales of MHC-I and MHC-II will be US$6.63 million and US$4.29 million, respectively.

This report presents a comprehensive overview, market shares, and growth opportunities of Major Histocompatibility Complex (MHC) Tetramer market by product type, application, key players and key regions and countries.

Segmentation by Type:
  • MHC-I
  • MHC-II
Segmentation by Application:
  • Cancer research
  • Virus research
  • Bacteria research
  • Other
This report also splits the market by region:
  • United States
  • China
  • Europe
  • Other regions
    • Japan
    • South Korea
    • Southeast Asia
    • Rest of world
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
  • MBL Life Science
  • ProImmune
  • BioLegend
  • KACTUS
  • Creative Biolabs
  • immunAware
  • HELIXGEN
  • ACROBiosystems
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Major Histocompatibility Complex (MHC) Tetramer Market Size 2025-2031
  2.1.2 Major Histocompatibility Complex (MHC) Tetramer Market Size CAGR by Region
2.2 Major Histocompatibility Complex (MHC) Tetramer Segment by Type
  2.2.1 MHC-I
  2.2.2 MHC-II
2.3 Major Histocompatibility Complex (MHC) Tetramer Market Size by Type
  2.3.1 Global Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Type (2025-2031)
  2.3.2 Global Major Histocompatibility Complex (MHC) Tetramer Market Size Growth Rate by Type (2025-2031)
2.4 Major Histocompatibility Complex (MHC) Tetramer Segment by Application
  2.4.1 Cancer research
  2.4.2 Virus research
  2.4.3 Bacteria research
  2.4.4 Other
2.5 Major Histocompatibility Complex (MHC) Tetramer Market Size by Application (2025-2031)
  2.5.1 Global Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Application (2025-2031)
  2.5.2 Global Major Histocompatibility Complex (MHC) Tetramer Market Size Growth Rate by Application (2025-2031)

3 MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) TETRAMER KEY PLAYERS

3.1 Date of Key Players Enter into Major Histocompatibility Complex (MHC) Tetramer
3.2 Key Players Major Histocompatibility Complex (MHC) Tetramer Product Offered
3.3 Key Players Major Histocompatibility Complex (MHC) Tetramer Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players Major Histocompatibility Complex (MHC) Tetramer Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) TETRAMER BY REGIONS

4.1 Major Histocompatibility Complex (MHC) Tetramer Market Size by Regions (2025-2031)
4.2 United States Major Histocompatibility Complex (MHC) Tetramer Market Size Growth (2025-2031)
4.3 China Major Histocompatibility Complex (MHC) Tetramer Market Size Growth (2025-2031)
4.4 Europe Major Histocompatibility Complex (MHC) Tetramer Market Size Growth (2025-2031)
4.5 Rest of World Major Histocompatibility Complex (MHC) Tetramer Market Size Growth (2025-2031)

5 UNITED STATES

5.1 United States Major Histocompatibility Complex (MHC) Tetramer Market Size by Type (2025-2031)
5.2 United States Major Histocompatibility Complex (MHC) Tetramer Market Size by Application (2025-2031)

6 EUROPE

6.1 Europe Major Histocompatibility Complex (MHC) Tetramer Market Size by Type (2025-2031)
6.2 Europe Major Histocompatibility Complex (MHC) Tetramer Market Size by Application (2025-2031)

7 CHINA

7.1 China Major Histocompatibility Complex (MHC) Tetramer Market Size by Type (2025-2031)
7.2 China Major Histocompatibility Complex (MHC) Tetramer Market Size by Application (2025-2031)

8 REST OF WORLD

8.1 Rest of World Major Histocompatibility Complex (MHC) Tetramer Market Size by Type (2025-2031)
8.2 Rest of World Major Histocompatibility Complex (MHC) Tetramer Market Size by Application (2025-2031)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) TETRAMER

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 MBL Life Science
  11.1.1 MBL Life Science Company Details
  11.1.2 MBL Life Science Major Histocompatibility Complex (MHC) Tetramer Product Offered
  11.1.3 MBL Life Science Major Histocompatibility Complex (MHC) Tetramer Market Size (2024 VS 2030)
  11.1.4 MBL Life Science Main Business Overview
  11.1.5 MBL Life Science News
11.2 ProImmune
  11.2.1 ProImmune Company Details
  11.2.2 ProImmune Major Histocompatibility Complex (MHC) Tetramer Product Offered
  11.2.3 ProImmune Major Histocompatibility Complex (MHC) Tetramer Market Size (2024 VS 2030)
  11.2.4 ProImmune Main Business Overview
  11.2.5 ProImmune News
11.3 BioLegend
  11.3.1 BioLegend Company Details
  11.3.2 BioLegend Major Histocompatibility Complex (MHC) Tetramer Product Offered
  11.3.3 BioLegend Major Histocompatibility Complex (MHC) Tetramer Market Size (2024 VS 2030)
  11.3.4 BioLegend Main Business Overview
  11.3.5 BioLegend News
11.4 KACTUS
  11.4.1 KACTUS Company Details
  11.4.2 KACTUS Major Histocompatibility Complex (MHC) Tetramer Product Offered
  11.4.3 KACTUS Major Histocompatibility Complex (MHC) Tetramer Market Size (2024 VS 2030)
  11.4.4 KACTUS Main Business Overview
  11.4.5 KACTUS News
11.5 Creative Biolabs
  11.5.1 Creative Biolabs Company Details
  11.5.2 Creative Biolabs Major Histocompatibility Complex (MHC) Tetramer Product Offered
  11.5.3 Creative Biolabs Major Histocompatibility Complex (MHC) Tetramer Market Size (2024 VS 2030)
  11.5.4 Creative Biolabs Main Business Overview
  11.5.5 Creative Biolabs News
11.6 immunAware
  11.6.1 immunAware Company Details
  11.6.2 immunAware Major Histocompatibility Complex (MHC) Tetramer Product Offered
  11.6.3 immunAware Major Histocompatibility Complex (MHC) Tetramer Market Size (2024 VS 2030)
  11.6.4 immunAware Main Business Overview
  11.6.5 immunAware News
11.7 HELIXGEN
  11.7.1 HELIXGEN Company Details
  11.7.2 HELIXGEN Major Histocompatibility Complex (MHC) Tetramer Product Offered
  11.7.3 HELIXGEN Major Histocompatibility Complex (MHC) Tetramer Market Size (2024 VS 2030)
  11.7.4 HELIXGEN Main Business Overview
  11.7.5 HELIXGEN News
11.8 ACROBiosystems
  11.8.1 ACROBiosystems Company Details
  11.8.2 ACROBiosystems Major Histocompatibility Complex (MHC) Tetramer Product Offered
  11.8.3 ACROBiosystems Major Histocompatibility Complex (MHC) Tetramer Market Size (2024 VS 2030)
  11.8.4 ACROBiosystems Main Business Overview
  11.8.5 ACROBiosystems News

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Major Histocompatibility Complex (MHC) Tetramer Market Size CAGR by Region (2025-2031) ($ millions)
Table 2. Major Players of MHC-I
Table 3. Major Players of MHC-II
Table 4. Global Market Size by Type (2025-2031) ($ millions)
Table 5. Global Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Type (2025-2031)
Table 6. Global Major Histocompatibility Complex (MHC) Tetramer Market Size by Application (2025-2031) ($ millions)
Table 7. Global Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Application (2025-2031)
Table 8. Date of Global Key Players Enter into Major Histocompatibility Complex (MHC) Tetramer Market
Table 9. Global Key Players Major Histocompatibility Complex (MHC) Tetramer Product Offered
Table 10. Key Players Major Histocompatibility Complex (MHC) Tetramer Funding/Investment (Million USD)
Table 11. Funding/Investment by Regions
Table 12. Funding/Investment by End-Industry
Table 13. Key Players Major Histocompatibility Complex (MHC) Tetramer Valuation & Market Capitalization (Million USD)
Table 14. Key Players Mergers & Acquisitions, Expansion Plans
Table 15. Major Histocompatibility Complex (MHC) Tetramer New Product/Technology Launches
Table 16. Major Histocompatibility Complex (MHC) Tetramer Industry Partnerships, Agreements, and Collaborations
Table 17. Major Histocompatibility Complex (MHC) Tetramer Industry Mergers and Acquisitions
Table 18. Global Major Histocompatibility Complex (MHC) Tetramer Market Size by Regions 2025-2031 ($ millions)
Table 19. Global Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Regions 2025-2031
Table 20. United States Major Histocompatibility Complex (MHC) Tetramer Market Size by Type (2025-2031) ($ millions)
Table 21. United States Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Type (2025-2031)
Table 22. United States Major Histocompatibility Complex (MHC) Tetramer Market Size by Application (2025-2031) ($ millions)
Table 23. United States Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Application (2025-2031)
Table 24. Europe Major Histocompatibility Complex (MHC) Tetramer Market Size by Type (2025-2031) ($ millions)
Table 25. Europe Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Type (2025-2031)
Table 26. Europe Major Histocompatibility Complex (MHC) Tetramer Market Size by Application (2025-2031) ($ millions)
Table 27. Europe Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Application (2025-2031)
Table 28. China Major Histocompatibility Complex (MHC) Tetramer Market Size by Type (2025-2031) ($ millions)
Table 29. China Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Type (2025-2031)
Table 30. China Major Histocompatibility Complex (MHC) Tetramer Market Size by Application (2025-2031) ($ millions)
Table 31. China Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Application (2025-2031)
Table 32. Rest of World Major Histocompatibility Complex (MHC) Tetramer Market Size by Type (2025-2031) ($ millions)
Table 33. Rest of World Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Type (2025-2031)
Table 34. Rest of World Major Histocompatibility Complex (MHC) Tetramer Market Size by Application (2025-2031) ($ millions)
Table 35. Rest of World Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Application (2025-2031)
Table 36. Key Market Drivers & Growth Opportunities of Major Histocompatibility Complex (MHC) Tetramer
Table 37. Key Market Challenges & Risks of Major Histocompatibility Complex (MHC) Tetramer
Table 38. Key Industry Trends of Major Histocompatibility Complex (MHC) Tetramer
Table 39. Company A Company Details
Table 40. Companies Invested by Company A
Table 41. Company A Key Development and Market Layout
Table 42. Company B Company Details
Table 43. Companies Invested by Company B
Table 44. Company B Key Development and Market Layout
Table 45. Company C Company Details
Table 46. Companies Invested by Company C
Table 47. Company C Key Development and Market Layout
Table 48. MBL Life Science Basic Information, Head Office, Major Market Areas and Its Competitors
Table 49. MBL Life Science Major Histocompatibility Complex (MHC) Tetramer Market Size (2024 VS 2030)
Table 50. ProImmune Basic Information, Head Office, Major Market Areas and Its Competitors
Table 51. ProImmune Major Histocompatibility Complex (MHC) Tetramer Market Size (2024 VS 2030)
Table 52. BioLegend Basic Information, Head Office, Major Market Areas and Its Competitors
Table 53. BioLegend Major Histocompatibility Complex (MHC) Tetramer Market Size (2024 VS 2030)
Table 54. KACTUS Basic Information, Head Office, Major Market Areas and Its Competitors
Table 55. KACTUS Major Histocompatibility Complex (MHC) Tetramer Market Size (2024 VS 2030)
Table 56. Creative Biolabs Basic Information, Head Office, Major Market Areas and Its Competitors
Table 57. Creative Biolabs Major Histocompatibility Complex (MHC) Tetramer Market Size (2024 VS 2030)
Table 58. immunAware Basic Information, Head Office, Major Market Areas and Its Competitors
Table 59. immunAware Major Histocompatibility Complex (MHC) Tetramer Market Size (2024 VS 2030)
Table 60. HELIXGEN Basic Information, Head Office, Major Market Areas and Its Competitors
Table 61. HELIXGEN Major Histocompatibility Complex (MHC) Tetramer Market Size (2024 VS 2030)
Table 62. ACROBiosystems Basic Information, Head Office, Major Market Areas and Its Competitors
Table 63. ACROBiosystems Major Histocompatibility Complex (MHC) Tetramer Market Size (2024 VS 2030)



LIST OF FIGURES

Figure 1. Picture of Major Histocompatibility Complex (MHC) Tetramer
Figure 2. Major Histocompatibility Complex (MHC) Tetramer Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Major Histocompatibility Complex (MHC) Tetramer Market Size Growth Rate 2025-2031 ($ millions)
Figure 7. Major Histocompatibility Complex (MHC) Tetramer Market Size by Region (2024 & 2031) ($ millions)
Figure 8. Global Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Type (2025-2031)
Figure 9. Global MHC-I Market Size Growth Rate
Figure 10. Global MHC-II Market Size Growth Rate
Figure 11. Major Histocompatibility Complex (MHC) Tetramer in Cancer research
Figure 12. Global Major Histocompatibility Complex (MHC) Tetramer Market: Cancer research (2025-2031) ($ millions)
Figure 13. Major Histocompatibility Complex (MHC) Tetramer in Virus research
Figure 14. Global Major Histocompatibility Complex (MHC) Tetramer Market: Virus research (2025-2031) ($ millions)
Figure 15. Major Histocompatibility Complex (MHC) Tetramer in Bacteria research
Figure 16. Global Major Histocompatibility Complex (MHC) Tetramer Market: Bacteria research (2025-2031) ($ millions)
Figure 17. Major Histocompatibility Complex (MHC) Tetramer in Other
Figure 18. Global Major Histocompatibility Complex (MHC) Tetramer Market: Other (2025-2031) ($ millions)
Figure 19. Global Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Application (2025-2031)
Figure 20. Global Major Histocompatibility Complex (MHC) Tetramer Market Size in Cancer research Growth Rate
Figure 21. Global Major Histocompatibility Complex (MHC) Tetramer Market Size in Virus research Growth Rate
Figure 22. Funding/Investment
Figure 23. Global Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Regions 2025-2031
Figure 24. United States Major Histocompatibility Complex (MHC) Tetramer Market Size 2025-2031 ($ millions)
Figure 25. China Major Histocompatibility Complex (MHC) Tetramer Market Size 2025-2031 ($ millions)
Figure 26. Europe Major Histocompatibility Complex (MHC) Tetramer Market Size 2025-2031 ($ millions)
Figure 27. Rest of World Major Histocompatibility Complex (MHC) Tetramer Market Size 2025-2031 ($ millions)
Figure 28. United States Major Histocompatibility Complex (MHC) Tetramer Consumption Market Share by Type in 2029
Figure 29. United States Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Application in 2029
Figure 30. Europe Major Histocompatibility Complex (MHC) Tetramer Consumption Market Share by Type in 2029
Figure 31. Europe Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Application in 2029
Figure 32. China Major Histocompatibility Complex (MHC) Tetramer Consumption Market Share by Type in 2029
Figure 33. China Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Application in 2029
Figure 34. Rest of World Major Histocompatibility Complex (MHC) Tetramer Consumption Market Share by Type in 2029
Figure 35. Rest of World Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share by Application in 2029